A global leading company focused on improving how scientists utilize knowledge & data to predict the properties/outcomes of pharmaceutical & biotech agents.
Joined September 2011
- Tweets 3,803
- Following 599
- Followers 918
- Likes 864
2,464 Photos and videos
Optimizing oncology dosing isn’t just about efficacy it’s about balancing exposure, safety, and variability with a data-driven approach. In our webinar, FDA experts Hao Zhu & Brian Booth discuss modern dose optimization strategies. Watch on demand: simulations-plus.com/events/…
13
Whether evaluating covariates, assessing biological plausibility, or extrapolating to new populations & dosing regimens, interpretability can be critical.
Explore Sandra Suarez-Sharp's latest insights on model interpretability and regulatory confidence. simulations-plus.com/resourc…
12
In a recent interview with Fierce Biotech, Associate Vice President of Global Sales Peter Kilford sat down with Rebecca Willumson to discuss the use of AI in drug development.
Watch the full interview: fiercebiotech.com/sponsored/…
7
Join Simulations Plus as an Associate Product Specialist, Monolix® in France. Work at the intersection of science, software, and innovation while helping advance one of the industry’s leading modeling platforms. Apply today: simulations-plus.com/career-…
8
Join us for GastroPlus Summer School, a hands-on 3-day workshop.
This workshop introduces participants to the GastroPlus® API and demonstrates how it can be used to streamline both basic and advanced modeling workflows
Register here: simulations-plus.com/events/…
17
Building and validating QSP models can take months, while external models often require learning new platforms. QSP Flex changes that—bringing validated QSP models into MATLAB®, Julia, Simbiology®, Monolix®, and Thales™. Learn more: simulations-plus.com/qsp-fle…
27
In a collaboration with the Polish Academy of Sciences, compounds designed using the AIDD module in ADMET Predictor® were synthesized & tested in vitro. Of 27 compounds evaluated, 70% significantly inhibited RORγT activity.
Learn more simulations-plus.com/resourc… #30YearsOfInnovation
21
We’re hiring a Senior Director, Pharmacometrics! Lead PK/PD modeling, simulation strategy, and regulatory support while mentoring teams and collaborating with innovative biopharma partners. Remote flexibility, scientific impact, and strategic influence. simulations-plus.com/career-…
1
36
Thank you to everyone who braved the weather to join us for our second annual Quiz Night at PAGE. We hope you enjoyed the friendly competition as much as we did!
21
Obesity drug development is evolving fast—from oral GLP-1s to multi-mechanism therapies. Join Dr. Scott Q. Siler for a first look at the updated OBESITYsym model, now expanded to simulate new oral and multi-agonist treatments.
Register now.
go.slp-marketing.com/2026-06…
30
Thank you to everyone who attended our PAGE pre-conference labs on modeling and AI! If you missed a session or have questions, stop by Booth #20 to chat with our instructors.
Don't miss the 2nd Annual Quiz Night tomorrow at Nocturno Bar. #PAGE2026
31
What does it take to understand & predict the behavior of LAIs? Join Deanna Mudie & Jim Mullin at DISSO on June 16 at 12 PM for Deciphering the Depot: Mechanistic PBPK Modeling and Population Balance Strategies for Long-Acting Injectables.
simulations-plus.com/events/…
47
If you’re attending PAGE 2026, be sure to join us for Quiz Night at the Valamar Lacroma Hotel, Nocturno Bar on Wednesday, June 3, from 6:00–8:00 PM for an evening of trivia, drinks, appetizers, & conversation with fellow PAGE attendees.
Register here: go.slp-marketing.com/PAGE202…
29
Obesity drug development is evolving fast—from oral GLP-1s to multi-mechanism therapies. Join Dr. Scott Q. Siler for a first look at the updated OBESITYsym model, now expanded to simulate new oral and multi-agonist treatments. Register now. go.slp-marketing.com/2026-06…
35
Regulatory decisions depend on model credibility, not just model output. Without transparency, it becomes harder to evaluate assumptions, verify results, or build confidence in model-informed strategies. Sandra Suarez-Sharp explores more: simulations-plus.com/resourc…
29
Regulatory decisions depend on model credibility, not just model output. Without transparency, it becomes harder to evaluate assumptions, verify results, or build confidence in model-informed strategies. Sandra Suarez-Sharp explores more: simulations-plus.com/resourc…
1
44
There’s still time to register for tomorrow’s webinar!
Moderated by Yu-Nien (Tom) Sun, PhD, the webinar will cover a range of topics, including the next big hurdle in dose selection: combination regimens.
Register today: go.slp-marketing.com/2026-05…
90
If you’re attending PAGE 2026, be sure to join us for Quiz Night at the Valamar Lacroma Hotel, Nocturno Bar on Wednesday, June 3, from 6:00–8:00 PM for an evening of trivia, drinks, appetizers, & conversation with fellow PAGE attendees.
Register here
go.slp-marketing.com/PAGE202…
25
#concQT analysis is tedious, time-consuming… and required. But now, you can automate it.
With our conc-QTc R package, you can automate these 3 key steps: data pre-processing, conc-QTc modeling using the white model, & report generation.
Learn more: monolixsuite.slp-software.co…
36
With QSP Flex, you can use validated QSP models in the modeling environment your team already knows, whether that’s MATLAB, Julia, Simbiology, Monolix or Thales.
Learn more about what models are now available with QSP Flex: simulations-plus.com/qsp-fle…
32